Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.
DeBiasi
Roberta L
RL
Pediatrics (Infectious Diseases), University of Colorado Health Sciences Center, 4200 East 9th Avenue, Box B055, Denver, CO 80262, USA. roberta.debiasi@uchsc.edu
Robinson
Bridget A
BA
Sherry
Barbara
B
Bouchard
Ron
R
Brown
R Dale
RD
Rizeq
Mona
M
Long
Carlin
C
Tyler
Kenneth L
KL
D000818:Animals; D017209:Apoptosis; D053148:Caspase 3; D061945:Caspase Inhibitors; D020169:Caspases / Q000235:genetics / Q000378:metabolism; D006321:Heart / Q000821:virology*; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009205:Myocarditis / Q000401:mortality / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D009206:Myocardium / Q000473:pathology; D012087:Reoviridae / Q000472:pathogenicity*; D019562:Viral Load
D061945:Caspase Inhibitors; C505407:CASP3 protein, human; C505409:Casp3 protein, mouse; D053148:Caspase 3; D020169:Caspases